BRAIN Biotech AG (XTER:BNN) Inventories, Finished Goods: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:BNN BRAIN Biotech AG XTER:BNN
60 GF Score
Price €2.91
GF Value €2.00
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is BRAIN Biotech AG Inventories, Finished Goods?

BRAIN Biotech AG XTER:BNN +6.99% 60 Inventories, Finished Goods is €0.00 Mil as of Jun. 2026. GuruFocus rates XTER:BNN with a GF Score™ of 60/100 and a GF Value™ of €2.00 (Significantly Overvalued). The stock has 3 warning signs investors should review.

BRAIN Biotech AG's annual finished goods declined from Sep. 2023 (€6.39 Mil) to Sep. 2024 (€6.26 Mil) but then increased from Sep. 2024 (€6.26 Mil) to Sep. 2025 (€6.64 Mil).

BRAIN Biotech AG Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for BRAIN Biotech AG's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BRAIN Biotech AG Inventories, Finished Goods Chart

BRAIN Biotech AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.64 5.95 6.39 6.26 6.64

BRAIN Biotech AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec25 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XTER:BNN
60GF Score
BRAIN Biotech AG XTER:BNN
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BRAIN Biotech AG Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €0.00 Mil mean?
BRAIN Biotech AG (XTER:BNN) has a Inventories, Finished Goods of €0.00 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on BRAIN Biotech AG and its competitors.
Is BRAIN Biotech AG's Inventories, Finished Goods too high?
BRAIN Biotech AG's current Inventories, Finished Goods is €0.00 Mil. Overall, BRAIN Biotech AG has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BRAIN Biotech AG's Inventories, Finished Goods compare to LIN and SHW?
BRAIN Biotech AG's Inventories, Finished Goods of €0.00 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Chemicals company?
A good Inventories, Finished Goods depends on the Chemicals industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on BRAIN Biotech AG and its competitors. BRAIN Biotech AG's current Inventories, Finished Goods is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BRAIN Biotech AG stock overvalued right now?
Based on GuruFocus' analysis, BRAIN Biotech AG (XTER:BNN) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.00, compared to a current price of €2.91 — trading 45.5% above its estimated fair value. The current Inventories, Finished Goods is €0.00 Mil. BRAIN Biotech AG's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For BRAIN Biotech AG (XTER:BNN), the current Inventories, Finished Goods is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BRAIN Biotech AG (XTER:BNN) Overvalued in 2026?

Based on GuruFocus' analysis, BRAIN Biotech AG stock appears to be overvalued. The current stock price of €2.91 is trading 45.5% above its estimated GF Value™ of €2.00. GuruFocus considers BRAIN Biotech AG to be Significantly Overvalued.

Key valuation signals for XTER:BNN:

  • Inventories, Finished Goods: €0.00 Mil
  • GF Value™: €2.00 vs. price of €2.91 (45.5% above fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the XTER:BNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BRAIN Biotech AG Business Description

Other Exchanges 0RFI:UK
Address Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is an industrial biotechnology specialist focused on enzyme technology, microbial production strains, and bioprocess design to enable bio-based innovations. The Group conducts research, development, and production for client specifications and its own product portfolio, supporting customers in the food and beverage, chemical, and life sciences industries with solutions that enhance productivity, efficiency, and sustainability. Its operations are organized into two segments: BRAIN Biocatalysts, which develops, produces, and distributes specialty enzymes, microorganisms, and ingredients and generates the majority of revenue, and BRAIN BioIncubator, which focuses on development projects. The company operates in Germany and other countries.
60GF Score

Get the complete analysis for XTER:BNN

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.91
Price
€2.00
GF Value